437 related articles for article (PubMed ID: 30419833)
1. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases.
Van Tong H; Van Ba N; Hoan NX; Binh MT; Quyen DT; Son HA; Van Luong H; Quyet D; Meyer CG; Song LH; Toan NL; Velavan TP
BMC Infect Dis; 2018 Nov; 18(1):553. PubMed ID: 30419833
[TBL] [Abstract][Full Text] [Related]
2. Interferon-stimulated gene 15 in hepatitis B-related liver diseases.
Hoan NX; Van Tong H; Giang DP; Toan NL; Meyer CG; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2016 Oct; 7(42):67777-67787. PubMed ID: 27626177
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
El-Mesery M; El-Mowafy M; Elgaml A; Youssef LF; Abed SY
J Interferon Cytokine Res; 2017 Aug; 37(8):342-347. PubMed ID: 28609212
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
5. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
6. Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
Tong HV; Song le H; Hoan NX; Cuong BK; Sy BT; Son HA; Quyet D; Binh VQ; Kremsner PG; Bock CT; Velavan TP; Toan NL
BMC Infect Dis; 2015 Jan; 15():25. PubMed ID: 25626490
[TBL] [Abstract][Full Text] [Related]
7. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W
Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients.
Hoan NX; Tong HV; Hecht N; Sy BT; Marcinek P; Meyer CG; Song le H; Toan NL; Kurreck J; Kremsner PG; Bock CT; Velavan TP
EBioMedicine; 2015 Dec; 2(12):2080-6. PubMed ID: 26844288
[TBL] [Abstract][Full Text] [Related]
9. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
11. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
12. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
13. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
[TBL] [Abstract][Full Text] [Related]
14. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
15. Serum Soluble Fibrinogen-Like Protein 2 Represents a Novel Biomarker for Differentiation Between Acute and Chronic Egyptian Hepatitis B Virus-Infected Patients.
El-Mesery M; El-Mowafy M; Youssef LF; El-Mesery A; Abed SY; Elgaml A
J Interferon Cytokine Res; 2021 Feb; 41(2):52-59. PubMed ID: 33621132
[TBL] [Abstract][Full Text] [Related]
16. Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.
Lu X; Xu Q; Bu X; Ma X; Zhang F; Deng Q; Zhang Y; Ding J
Int J Clin Exp Pathol; 2014; 7(9):6048-55. PubMed ID: 25337250
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
[TBL] [Abstract][Full Text] [Related]
19. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
[TBL] [Abstract][Full Text] [Related]
20. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
